Harry Keyserling MD
Academic Appointment
Education
Degrees
- MD from Georgetown University School of Medicine
- BA from Johns Hopkins University
Research
Focus
- Research is focused in the following areas: virology, particularly herpesviruses and enteroviruses; hospital epidemiology; and clinical vaccinology.
Publications
-
Close Your Eyes and See: Stroke Sequelae versus Functional Neurological Disorder in a Physician.
Eur Neurol Volume: 86 Page(s): 287 - 294
01/01/2023 Authors: Weil EJ; Keyserling H; Feuerstein B; Murphy O -
Identifying biopsychosocial factors that impact decompressive laminectomy outcomes in veterans with lumbar spinal stenosis: a prospective cohort study.
Pain Volume: 162 Page(s): 835 - 845
03/01/2021 Authors: Weiner DK; Holloway K; Levin E; Keyserling H; Epstein F; Monaco E; Sembrano J; Brega K; Nortman S; Krein SL -
DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trial.
PLoS One Volume: 13 Page(s): e0206837
01/01/2018 Authors: Houser KV; Yamshchikov GV; Bellamy AR; May J; Enama ME; Sarwar U; Larkin B; Bailer RT; Koup R; Paskel M -
Humoral and Cell-Mediated Immune Responses to Alternate Booster Schedules of Anthrax Vaccine Adsorbed in Humans.
Clin Vaccine Immunol Volume: 23 Page(s): 326 - 338
04/01/2016 Authors: Quinn CP; Sabourin CL; Schiffer JM; Niemuth NA; Semenova VA; Li H; Rudge TL; Brys AM; Mittler RS; Ibegbu CC -
Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-nave subjects.
Vaccine Volume: 33 Page(s): 5225 - 5234
09/22/2015 Authors: Frey SE; Wald A; Edupuganti S; Jackson LA; Stapleton JT; El Sahly H; El-Kamary SS; Edwards K; Keyserling H; Winokur P -
Safety and Immunogenicity of Full-Dose Trivalent Inactivated Influenza Vaccine (TIV) Compared With Half-Dose TIV Administered to Children 6 Through 35 Months of Age.
J Pediatric Infect Dis Soc Volume: 4 Page(s): 214 - 224
09/01/2015 Authors: Halasa NB; Gerber MA; Berry AA; Anderson EL; Winokur P; Keyserling H; Eckard AR; Hill H; Wolff MC; McNeal MM -
Cytomegalovirus viral and antibody correlates in young children.
BMC Res Notes Volume: 7 Page(s): 776
11/03/2014 Authors: Dollard SC; Keyserling H; Radford K; Amin MM; Stowell J; Winter J; Schmid DS; Cannon MJ; Hyde TB -
Impact of body mass index on immunogenicity of pandemic H1N1 vaccine in children and adults.
J Infect Dis Volume: 210 Page(s): 1270 - 1274
10/15/2014 Authors: Callahan ST; Wolff M; Hill HR; Edwards KM; NIAID Vaccine and Treatment Evaluation Unit (VTEU) Pandemic H1N1 Vaccine Study Group -
Evaluation of sex, race, body mass index and pre-vaccination serum progesterone levels and post-vaccination serum anti-anthrax protective immunoglobulin G on injection site adverse events following anthrax vaccine adsorbed (AVA) in the CDC AVA human clinical trial.
Vaccine Volume: 32 Page(s): 3548 - 3554
06/12/2014 Authors: Pondo T; Rose CE; Martin SW; Keitel WA; Keyserling HL; Babcock J; Parker S; Jacobson RM; Poland GA; McNeil MM -
Effect of reduced dose schedules and intramuscular injection of anthrax vaccine adsorbed on immunological response and safety profile: a randomized trial.
Vaccine Volume: 32 Page(s): 1019 - 1028
02/12/2014 Authors: Wright JG; Plikaytis BD; Rose CE; Parker SD; Babcock J; Keitel W; El Sahly H; Poland GA; Jacobson RM; Keyserling HL